Lymphadenopathy risk factors

Jump to navigation Jump to search

Lymphadenopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphadenopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphadenopathy risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphadenopathy risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphadenopathy risk factors

CDC on Lymphadenopathy risk factors

Lymphadenopathy risk factors in the news

Blogs on Lymphadenopathy risk factors

Directions to Hospitals Treating Lymphadenopathy

Risk calculators and risk factors for Lymphadenopathy risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]Raviteja Guddeti, M.B.B.S. [3]Delband Yekta Moazami, M.D.[4] Ogechukwu Hannah Nnabude, MD

Overview

Common risk factors in the development of lymphadenopathy include people at risk of infections as seen in high-risk sexual behavior for HIV,Cytomegalovirus, IV drug users, recent blood transfusion. HIV is a lymphotropic virus that activates lymph node remodeling. Lymph nodes that clinically manifest as persistent at a pathological stage Three distinct stages of lymphadenopathy include stage I, explosive follicular disease Big germinal centers of hyperplasia, stage II, germinal centers depletion of lymphocytes and central involution, and step III, proliferation Within the lymph nodes, blood vessels

Risk Factors

Common Risk Factors

Less Common Risk Factors

References

  1. Freeman AM, Matto P. PMID 30020622. Missing or empty |title= (help)
  2. Glushko T, He L, McNamee W, Babu AS, Simpson SA (February 2021). "HIV Lymphadenopathy: Differential Diagnosis and Important Imaging Features". AJR Am J Roentgenol. 216 (2): 526–533. doi:10.2214/AJR.19.22334. PMID 33325733 Check |pmid= value (help).
  3. Bogoch II, Andrews JR, Nagami EH, Rivera AM, Gandhi RT, Stone D (March 2013). "Clinical predictors for the aetiology of peripheral lymphadenopathy in HIV-infected adults". HIV Med. 14 (3): 182–6. doi:10.1111/j.1468-1293.2012.01035.x. PMC 3562378. PMID 22805116.

Template:WH Template:WS